Selective synthesis of novel quinolones-amino esters as potential antibacterial and antifungal agents: Experimental, mechanistic study, docking and molecular dynamic simulations
“…In the same context, its docking with the crystal structure of Mcl-1 in the Maestro package implemented in Schrodinger software gave rise to a good docking score. [36,37] As expected, Table 8 exhibits its high activity according to these models, confirming that the proposed ligand is found very active and can be a Taking into account the inhibitory activity predicted values of the proposed compound as well as its docking score, which are very encouraging, it deserves to be tested in-vitro for more evaluating its activity against Mcl-1 protein. For further analysis to confirm the favorable interaction between the designed inhibitors and the binding site of the Mcl-1 protein, we evaluated the 2D and 3D interactions of the complex formed by them.…”
Section: Design and Evaluate The Interaction Of The Designed Compound...supporting
confidence: 76%
“…In the same context, its docking with the crystal structure of Mcl‐1 in the Maestro package implemented in Schrodinger software gave rise to a good docking score. [ 36,37 ]…”
In this study, a quantitative structure‐activity relationship (QSAR) model of anticancer activity against myeloid cell leukemia 1 (Mcl‐1) for a series of 41 tricyclic indole diazepinone derivatives is established. Three different modeling methods, multiple linear regression (MLR), partial least square (PLS), and artificial neural network (ANN) are investigated to perform a QSAR model with significant predictiveness. A clustering method is also used for dividing all compounds into training and external test (ET) sets. Component principal analysis is used to eliminate the redundancy between descriptors. The accuracy and predictability of the proposed models are proven by comparing their key statistical terms. The good results obtained with the internal and external validations (EV) show that the proposed models can predict high‐performance activities and that the selected descriptors are pertinent. This model is also validated using internal validation (IV), mainly using cross‐validation (leave‐many‐out (LMOCV)). The applicability domain (AD) is identified. Based on the SAR map analysis, a novel Mcl‐1 inhibitor with a good predicted activity using the best model is proposed, the interaction of the designed compound with the binding site of Mcl‐1 protein is evaluated and its docking score is found high.
“…In the same context, its docking with the crystal structure of Mcl-1 in the Maestro package implemented in Schrodinger software gave rise to a good docking score. [36,37] As expected, Table 8 exhibits its high activity according to these models, confirming that the proposed ligand is found very active and can be a Taking into account the inhibitory activity predicted values of the proposed compound as well as its docking score, which are very encouraging, it deserves to be tested in-vitro for more evaluating its activity against Mcl-1 protein. For further analysis to confirm the favorable interaction between the designed inhibitors and the binding site of the Mcl-1 protein, we evaluated the 2D and 3D interactions of the complex formed by them.…”
Section: Design and Evaluate The Interaction Of The Designed Compound...supporting
confidence: 76%
“…In the same context, its docking with the crystal structure of Mcl‐1 in the Maestro package implemented in Schrodinger software gave rise to a good docking score. [ 36,37 ]…”
In this study, a quantitative structure‐activity relationship (QSAR) model of anticancer activity against myeloid cell leukemia 1 (Mcl‐1) for a series of 41 tricyclic indole diazepinone derivatives is established. Three different modeling methods, multiple linear regression (MLR), partial least square (PLS), and artificial neural network (ANN) are investigated to perform a QSAR model with significant predictiveness. A clustering method is also used for dividing all compounds into training and external test (ET) sets. Component principal analysis is used to eliminate the redundancy between descriptors. The accuracy and predictability of the proposed models are proven by comparing their key statistical terms. The good results obtained with the internal and external validations (EV) show that the proposed models can predict high‐performance activities and that the selected descriptors are pertinent. This model is also validated using internal validation (IV), mainly using cross‐validation (leave‐many‐out (LMOCV)). The applicability domain (AD) is identified. Based on the SAR map analysis, a novel Mcl‐1 inhibitor with a good predicted activity using the best model is proposed, the interaction of the designed compound with the binding site of Mcl‐1 protein is evaluated and its docking score is found high.
“…The reaction of the 2‐quinolone derivatives with propargyl bromide under phase transfer catalysis (PTC)[ 52 , 53 , 54 , 55 ] conditions (liquid‐solid) in dimethylformamide in the presence of potassium carbonate and tetra‐n‐butylammonium bromide (TBAB) led to 1‐propargyl‐2‐quinolone ( 2 a , 2 b ) with good yields. The synthesis of the target compounds 2 a and 2 b was achieved by first preparing the quinolone‐carboxamides 1 a and 1 b using the coupling reaction between 2‐quinolone carboxylic acids ( a , b ) and L‐alanine‐OMe in the presence of HBTU as an activating agent and triethylamine (TEA) and chloroform (CHCl 3 ) as solvents for 12 hours at room temperature.…”
Due to the ever‐increasing antimicrobial resistance there is an urgent need to continuously design and develop novel antimicrobial agents. Inspired by the broad antibacterial activities of various heterocyclic compounds such as 2‐quinolone derivatives, we designed and synthesized new methyl‐(2‐oxo‐1,2‐dihydroquinolin‐4‐yl)‐L‐alaninate‐1,2,3‐triazole derivatives via 1,3‐dipolar cycloaddition reaction of 1‐propargyl‐2‐quinolone‐L‐alaninate with appropriate azide groups. The synthesized compounds were obtained in good yield ranging from 75 to 80 %. The chemical structures of these novel hybrid molecules were determined by spectroscopic methods and the antimicrobial activity of the compounds was investigated against both bacterial and fungal strains. The tested compounds showed significant antimicrobial activity and weak to moderate antifungal activity. Despite the evident similarity of the quinolone moiety of our compounds with fluoroquinolones, our compounds do not function by inhibiting DNA gyrase. Computational characterization of the compounds shows that they have attractive physicochemical and pharmacokinetic properties and could serve as templates for developing potential antimicrobial agents for clinical use.
“…This result is similar to those described in the literature for compounds containing the same substituents. 60 On the other hand, the Gram-negative bacteria E. coli is inhibited by almost the majority of the tested hybrid compounds with moderate to good antibacterial effect in comparison with the control. Among the evaluated hybrid compounds, compound 6g (Ar = p-OCH 3 (C 6 H 4 ), Ar 1 = p-NO 2 (C 6 H 4 )) is the most active against E. coli with an inhibition zone of (15 ± 01) mm and an inhibition rate of 62.5% compared to streptomycin (24 ± 1.5 mm).…”
A series of new heterocycle hybrids incorporating pyrazole
and
isoxazoline rings was successfully synthesized, characterized, and
evaluated for their antimicrobial responses. The synthesized compounds
were obtained utilizing N-alkylation and 1,3-dipolar
cycloaddition reactions, as well as their structures were established
through spectroscopic methods and confirmed by mass spectrometry.
To get more light on the regioselective synthesis of new hybrid compounds,
mechanistic studies were performed using DFT calculations with B3LYP/6-31G(d,p)
basis set. Additionally, the results of the preliminary screening
indicate that some of the examined hybrids showed potent antimicrobial
activity, compared to standard drugs. The results confirm that the
antimicrobial activity is strongly dependent on the nature of the
substituents linked pyrazole and isoxazoline rings. Furthermore, molecular
docking studies were conducted to highlight the interaction modes
between the investigated hybrid compounds and the Escherichia
coli and Candida albicans receptors.
Notably, the results demonstrate that the investigated compounds have
strong protein binding affinities. The stability of the formed complexes
by the binding between the hybrid compound 6c, and the
target proteins was also confirmed using a 100 ns molecular dynamics
simulation. Finally, the prediction of ADMET properties suggests that
almost all hybrid compounds possess good pharmacokinetic profiles
and no signs of observed toxicity, except for compounds 6e, 6f, and 6g.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.